Novalis LifeSciences Investments I, L.P.

Director, Footnote #1 (See Remarks) at DNA; Stockholder (1) see Remarks at Cerevel Therapeutics Holdings, Inc.

Sold, on record
None
Dollars the filings state
Form 4 sales
0
None on record
Form 144 notices
2
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

No Form 4 sale on record for Novalis LifeSciences Investments I, L.P..

Timeline

  1. 1 Form 144 notice Cerevel Therapeutics Holdings, Inc.Notice
    Jun 15, 2023 2023

    Filed to sell 200,000 shares ($6.9M)

    Novalis LifeSciences Investments I, L.P., Stockholder (1) see Remarks

    No 10b5-1 planFirst sale on recordFiling

  2. 2 Form 144 notice DNANotice
    May 16, 2024 +336 days

    Filed to sell 265,000 shares ($220k)

    Novalis LifeSciences Investments I, L.P., Director, Footnote #1 (See Remarks)

    No 10b5-1 planFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (2)

Form 144 notices and Form 4 sales by Novalis LifeSciences Investments I, L.P.
Source
May 16, 2024May 16, 2024DNADirector, Footnote #1 (See Remarks)Form 144 notice265,000$220kNoticeSEC
Jun 15, 2023Jun 15, 2023Cerevel Therapeutics Holdings, Inc.Stockholder (1) see RemarksForm 144 notice200,000$6.9MNoticeSEC